Specification of dividend and share buy-backs since stock market listing in 2000:
| (DKK million) |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
Total
|
| Dividend |
124 |
146 |
162 |
217 |
231 |
256 |
278 |
325 |
1,738 |
| Buy-backs |
8 |
424 |
185 |
392 |
847 |
1,053 |
1,107 |
500 |
4,516 |
| Total |
132 |
570 |
347 |
609 |
1,078 |
1,309 |
1,385 |
825 |
6,254 |
| Dividend/share (DKK) |
1.65 |
2.00 |
2.25 |
3.15 |
3.50 |
4.00 |
4.50 |
5.00 |
|
Dividend policy
Novozymes aims at a dividend pay-out ratio of at least 30% of net profit.
Share buy-backs
Novozymes adheres to the following principles when conducting share buy-backs:
- continuous daily buy-backs
-
the aim is to buy up to a maximum of 15% of the shares traded each day
- the buy-backs take place throughout the trading day
-
the open windows are up to 15 trading days prior to publication of group
financial statements, however share buy-backs will stop no later
when the group accounts are internally available
-
all share buy-backs respect the general rules on insider dealing
-
the share buy-backs are conducted via a number of independent stock
brokers/bankers
-
the stock market is notified on an ongoing basis of status
in connection with publication of group financial statements and
in compliance with the Danish Companies Act
(Last updated: (6/03/2008)